drugset / Trial / NCT00191932

Switching to Duloxetine From Other Antidepressants

NCT00191932

Phase 4 Completed 360 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

A multicentre, randomised, open label study of out-patients with major depression who have failed to respond adequately to antidepressant treatment for their current episode of depression. The study compares outcomes associated with two methods of switching from current antidepressant to duloxetine

Timeline

Start
2004-08
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule